"We need somewhere to smoke crack": An ethnographic study of an unsanctioned safer smoking room in Vancouver, Canada

International Journal of Drug Policy

Volumn 26, Issue 7, 2015, Pages 645-652

  McNeil, Ryan ^a,b   Kerr, Thomas ^a,c   Lampkin, Hugh ^d   Small, Will ^a,b  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d VANCOUVER AREA NETWORK OF DRUG USERS   (Canada)

Author keywords

Crack cocaine; Drug use; Harm reduction; Qualitative; Safer smoking rooms

Indexed keywords

COCAINE;

ADULT; ARTICLE; CANADA; ENVIRONMENT; ETHNOGRAPHIC RESEARCH; FEMALE; HEALTH HAZARD; HEALTH PROMOTION; HUMAN; MALE; PRIORITY JOURNAL; PUBLIC HEALTH; RISK REDUCTION; SAFER SMOKING ROOM; SELF REPORT; SMOKING; SMOKING REGULATION; SOCIAL CONTROL; SOCIAL NORM; SOCIAL SUPPORT; SOCIAL WELFARE; ADVERSE EFFECTS; BRITISH COLUMBIA; COCAINE-RELATED DISORDERS; COMPLICATION; DRUG USE; HARM REDUCTION; INFORMATION PROCESSING; MIDDLE AGED; PREVENTION AND CONTROL; VIOLENCE;

ADULT; BRITISH COLUMBIA; COCAINE-RELATED DISORDERS; CRACK COCAINE; DATA COLLECTION; DRUG USERS; FEMALE; HARM REDUCTION; HUMANS; MALE; MIDDLE AGED; SMOKING; SOCIAL SUPPORT; VIOLENCE;

EID: 84930767594     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2015.01.015     Document Type: Article

References (54)

1. Bourdieu P., Wacquant L. An invitation to reflexive sociology 1992, University of Chicago Press, Chicago, IL.
2. Bourgois P. In search of respect: Selling crack in El Barrio 1996, Cambridge University Press, New York, NY.
3. Bourgois P. The moral economies of homeless heroin addicts: Confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. Substance Use & Misuse 1998, 33(11):2323-2351.
4. Bourgois P. Recognizing invisible violence: A thirty-year ethnographic retrospective. Global health in times of violence 2009, 17-40. School for Advanced Research Press, Santa Fe, NM. B. Rylko-Bauer, L. Whiteford, P. Farmer (Eds.).
5. Bourgois P., Prince B., Moss A. The everyday violence of hepatitis C among young women who inject drugs in San Francisco. Human Organization 2004, 63(3):253-264.
6. Bungay V., Johnson J.L., Varcoe C., Boyd S. Women's health and use of crack cocaine in context: Structural and 'everyday' violence. Internation Journal of Drug Policy 2010, 21(4):321-329.
7. Boyd S., Johnson J.L., Moffat B. Opportunities to learn and barriers to change: Crack cocaine use in the Downtown Eastside of Vancouver. Harm Reduction Journal 2008, 5(34):1-12.
8. Collins C.L., Kerr T., Kuyper L.M., Li K., Tyndall M.W., Marsh D.C., et al. Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use. Journal of Urban Health 2005, 82(2):276-284.
9. DeBeck K., Buxton J., Kerr T., Qi J., Montaner J., Wood E. Public crack cocaine smoking and willingness to use a supervised inhalation facility: Implications for street disorder. Substance Abuse Treatment, Prevention & Policy 2011, 6:4.
10. DeBeck K., Kerr T., Li K., Fischer B., Buxton J., Montaner J., et al. Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. Canadian Medical Association Journal 2009, 181(9):585-589.
11. DeBeck K., Wood E., Zhang R., Tyndall M., Montaner J., Kerr T. Police and public health partnerships: Evidence from the evaluation of Vancouver's supervised injection facility. Substance Abuse Treatment Prevention & Policy 2008, 3(1):11.
12. Duff P., Tyndall M., Buxton J., Zhang R., Kerr T., Shannon K. Sex-for-crack exchanges: Associations with risky sexual and drug use niches in an urban Canadian city. Harm Reduction Journal 2013, 10:29.
13. Edlin B.R., Irwin K.L., Faruque S., McCoy C.B., Word C., Serrano Y., et al. Intersecting epidemics - Crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. New England Journal of Medicine 1994, 331(21):1422-1427.
14. Fairbairn N., Small W., Shannon K., Wood E., Kerr T. Seeking refuge from violence in street-based drug scenes: Women's experiences in North America's first supervised injection facility. Social Science & Medicine 2008, 67(5):817-823.
15. Falck R.S., Wang J., Siegal H.A., Carlson R.G. The prevalence of psychiatric disorder among a community sample of crack cocaine users: An exploratory study with practical implications. The Journal of Nervous and Mental Disease 2004, 192(7).
16. Farmer P. Pathologies of power: Health, human rights, and the new war on the poor 2003, University of California Press, Berkeley, CA.
17. Fischer B., Coghlan M. Crack use in North American cities: The neglected 'epidemic'. Addiction 2007, 102(9):1340-1341.
18. Fischer B., Powis J., Firestone Cruz M., Rudzinski K., Rehm J. Hepatitis C virus transmission among oral crack users: Viral detection on crack paraphernalia. European Journal of Gastroenterology & Hepatology 2008, 20(1):29-32.
19. Fischer B., Rehm J., Patra J., Kalousek K., Haydon E., Tyndall M., et al. Crack across Canada: Comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users. Addiction 2006, 101(12):1760-1770.
20. Fischer B., Rudzinski K., Ivsins A., Gallupe O., Patra J., Krajden M. Social, health and drug use characteristics of primary crack users in three mid-sized communities in British Columbia, Canada. Drugs: Education, Prevention, and Policy 2010, 17(4):333-353.
21. Gardy J.L., Johnston J.C., Sui S.J.H., Cook V.J., Shah L., Brodkin E., et al. Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. New England Journal of Medicine 2011, 364(8):730-739.
22. Haydon E., Fischer B. Crack use as a public health problem in Canada: Call for an evaluation of 'safer crack use kits'. Canadian Journal of Public Health 2005, 96(3):185-188.
23. Hedrich D. European report on drug consumption rooms 2004, EMCDDA, Lisbon, Portugal.
24. Hunt N. An overview of models of delivery of drug consumption rooms 2006, Joseph Rowntree Foundation, York, UK.
25. Ivsins A., Roth E., Benoit C., Fischer B. Crack pipe sharing in context: How sociostructural factors shape risk practices among noninjection drug users. Contemporary Drug Problems 2013, 40(4):481-503.
26. Kerr T., Small W., Peeace W., Douglas D., Pierre A., Wood E. Harm reduction by a user-run organization: A case study of the Vancouver Area Network of Drug Users (VANDU). International Journal of Drug Policy 2006, 17(2):61-69.
27. Kral A.H., Bluthenthal R.N., Booth R.E., Watters J.K. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. American Journal of Public Health 1998, 88(1):108-113.
28. Leonard L., DeRubeis E., Pelude L., Medd E., Birkett N., Seto J. I inject less as I have easier access to pipes: Injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. International Journal of Drug Policy 2008, 19(3):255-264.
29. Malchy L.A., Bungay V., Johnson J.L., Buxton J. Do crack smoking practices change with the introduction of safer crack kits?. Canadian Journal of Public Health 2011, 102(3):188-192.
30. Marshall B.D.L., Milloy M.J., Wood E., Montaner J.S.G., Kerr T. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: A retrospective population-based study. The Lancet 2011, 377(9775):1429-1437.
31. McNeil R., Small W. 'Safer environment interventions': A qualitative synthesis of the experiences and perceptions of people who inject drugs. Social Science & Medicine 2014, 106:151-158.
32. McNeil R., Shannon K., Shaver L., Kerr T., Small W. Negotiating place and gendered violence in Canada's largest open drug scene. International Journal of Drug Policy 2014, 25(3):608-615.
33. McNeil R., Small W., Lampkin H., Shannon K., Kerr T. People knew they could come here to get help: An ethnographic study of assisted injection practices at a peer-run 'unsanctioned' supervised drug consumption room in a Canadian setting. AIDS and Behavior 2014, 18(3):473-485.
34. Moore D. 'Workers','clients' and the struggle over needs: Understanding encounters between service providers and injecting drug users in an Australian city. Social Science & Medicine 2009, 68(6):1161-1168.
35. Rhodes T., Singer M., Bourgois P., Friedman S.R., Strathdee S.A. The social structural production of HIV risk among injecting drug users. Social Science & Medicine 2005, 61(5):1026-1044.
36. Rhodes T., Watts L., Davies S., Martin A., Smith J., Clark D., et al. Risk, shame and the public injector: A qualitative study of drug injecting in South Wales. Social Science & Medicine 2007, 65(3):572-585.
37. Riddell C., Riddell R. Welfare checks, drug consumption, and health: Evidence from Vancouver Injection Drug Users. The Journal of Human Resources 2006, XLI(1):138-161.
38. Ross M.W., Hwang L.-Y., Zack C., Bull L., Williams M.L. Sexual risk behaviours and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. International Journal of STD & AIDS 2002, 13(11):769-774.
39. Roy É., Haley N., Leclerc P., Boivin J.-F., Cédras L., Vincelette J. Risk factors for hepatitis C virus infection among street youths. Canadian Medical Association Journal 2001, 165(5):557-560.
40. Schatz E., Nougier M. Drug consumption rooms: Evidence and practice 2012, International Drug Policy Consortium, London.
41. Scheinmann R., Hagan H., Lelutiu-Weinberger C., Stern R., Jarlais D.C.D., Flom P.L., et al. Non-injection drug use and Hepatitis C Virus: A systematic review. Drug & Alcohol Dependence 2007, 89(1):1-12.
42. Scheper-Hughes N. Death without weeping: The violence of everyday life in Brazil 1992, University of California Press, Berkeley, CA.
43. Scheper-Hughes N., Bourgois P. Introduction: Making sense of violence. Violence in war and peace: An anthology 2004, 1-32. Blackwell Publishing, Malden, MA. N. Scheper-Hughes, P. Bourgois (Eds.).
44. Shannon K., Ishida T., Morgan R., Bear A., Oleson M., Kerr T., et al. Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users. Harm Reduction Journal 2006, 3:1.
45. Small W., Ainsworth L., Wood E., Kerr T. IDU perspectives on the design and operation of North America's first medically supervised injection facility. Substance Use & Misuse 2010, 46(5):561-568.
46. Small W., Krusi A., Wood E., Montaner J., Kerr T. Street-level policing in the Downtown Eastside of Vancouver, Canada, during the 2010 winter Olympics. International Journal of Drug Policy 2012, 23(2):128-133.
47. Small W., Rhodes T., Wood E., Kerr T. Public injection settings in Vancouver: Physical environment, social context and risk. International Journal of Drug Policy 2007, 18(1):27-36.
48. Strike C., Watson T.M., Lavigne P., Hopkins S., Shore R., Young D., et al. Guidelines for better harm reduction: Evaluating implementation of best practice recommendations for needle and syringe programs (NSPs). International Journal of Drug Policy 2011, 22(1):34-40.
49. Ti L., Buxton J., Wood E., Zhang R., Montaner J., Kerr T. Difficulty accessing crack pipes and crack pipe sharing among people who use drugs in Vancouver, Canada. Substance Abuse Treatment Prevention & Policy 2011, 6:34.
50. Urban Health Research Initiative Drug situation in Vancouver 2013, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada. 2nd ed.
51. Werb D., Debeck K., Kerr T., Li K., Montaner J., Wood E. Modelling crack cocaine use trends over 10 years in a Canadian setting. Drug & Alcohol Review 2010, 29(3):271-277.
52. Wood E., Tyndall M.W., Montaner J.S., Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. Canadian Medical Association Journal 2006, 175(11):1399-1404.
53. Zlotorzynska M., Wood E., Montaner J.S., Kerr T. Supervised injection sites: Prejudice should not trump evidence of benefit. Canadian Medical Association Journal 2013, 185(15):1303-1304.
54. Zurhold H., Degkwitz P., Verthein U., Haasen C. Drug consumption rooms in Hamburg, Germany: Evaluation of the effects on harm reduction and the reduction of public nuisance. Journal of Drug Issues 2003, 33(3):663-688.